
|Articles|February 9, 2012
Robert Gamble Discusses Patient-Centered Medical Homes Option for Cancer Patients
Advertisement
Mr. Robert “Bo” Gamble, Director, Strategic Practice Initiatives, Community Oncology Alliance in Washington, DC, addresses how the ACO model isn’t a good fit for cancer care because of unpredictability and the high cost of oncology medications.
Mr. Gamble also discusses the standards set by the NCQA and why he thinks they are on target with coordination, outreach, and patient satisfaction, but that the value component is missing for cancer care.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
60% of US Women Face Barriers to Postpartum, Mental Health Care
4
Higher Weight-Adjusted Waist Index Tied to CKD Mortality, Study Finds
5




